Aller au contenu principal
Profil bibliographique

AL van de Ven

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

3Publications signalées
24Citations signalées
0Affiliations récentes

Les domaines associés

Nanoplatforms for cancer theranosticsNanoparticle-Based Drug DeliveryCancer survivorship and careNutrition and Health in AgingProtease and Inhibitor Mechanisms

Les publications récentes

Accès ouvert 2020 article OpenAlex

Effectiveness of a Tailored Work-Related Support Intervention for Patients Diagnosed with Gastrointestinal Cancer: A Multicenter Randomized Controlled Trial

A.C.G.N.M. Zaman, Kristien M.A.J. Tytgat, Jean H. G. Klinkenbijl, Frank C. den Boer et autres

Purpose The aim of this research was to study the effectiveness on return to work (RTW) of an early tailored work-related support intervention in patients diagnosed with curative gastrointestinal cancer. Methods A multicenter randomized controlled trial was undertaken, in which patients were …

nl, us (code pays fourni par la source)

24 citations Journal of Occupational Rehabilitation
2013 conference-abstract OpenAlex

Abstract P4-06-13: Discovering serum biomarkers for predicting accumulation of nanotherapeutics to different tumor and organ microenvironments

Kenji Yokoi, Tomonori Tanei, Biana Godin, AL van de Ven et autres

Abstract Surrogate biomarkers in the circulation for the enhanced permeation and retention (EPR) effect in different tumor and organ microenvironment shall aid in selecting patients who are likely to accumulate higher amount of nanotherapeutics to tumors and thus show better response to …

us (code pays fourni par la source)

0 citations Cancer Research
2012 conference-abstract OpenAlex

Abstract P6-11-12: Nanoparticle-enhanced chemotherapeutics delivery in drug-resistant triple-negative breast cancer

AL van de Ven, MD Landis, LA Paskett, Anne Meyn et autres

Abstract Chemotherapeutics delivery is generally poor in tumors characterized by rapid perfusion and low blood volume fraction. Systemically administered nanoparticles can be engineered to overcome abnormal flow conditions to act as intravascular drug depots for the localized delivery of high concentrations of …

us (code pays fourni par la source)

0 citations Cancer Research

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.